Puma Biotechnology to present its abstract at ESMO 2017

ME PubManu Team

Puma Biotechnology, Inc., a biopharmaceutical company announces the release of two abstracts on its drug neratinib. It will be presented at the European Society for Medical Oncology (ESMO) 2017 Congress, which is to be held from September 8 – 12 in Madrid, Spain.

Reference Link: http://markets.businessinsider.com/news/stocks/puma-biotechnology-announces-publication-of-abstracts-for-esmo-2017-1002296389

Related Posts

Peer reviewers of Springer Nature facilitate charity in developing countries

In accordance with the collaboration between Springer’s journal Environmental Earth Sciences and the non-profit humanitarian organization “Filter of Hope” whenever a peer reviewer completes a peer review for Environmental Earth Sciences, a water filter is donated to developing countries. This association has enabled the availability of safe drinking water in developing countries like Liberia, Nicaragua, […]

LIGO’s Enhanced Sensitivity Reveals New Cosmic Insights

  LIGO, the Laser Interferometer Gravitational-Wave Observatory, has achieved a remarkable advancement in sensitivity by employing a technique known as frequency-dependent squeezing. This innovative approach enables LIGO to transcend the quantum limitations that previously hindered its measurements. A substantial 60% increase in the detection rate of cataclysmic events, like the collision of black holes and […]

Skin Disease Awareness Campaign by American Academy of Dermatology

The American Academy of Dermatology (AAD) is launching an awareness campaign on skin diseases that is believed to have a profound impact on the US patients as well as the state’s economy. The campaign has been named as the “SkinSerious campaign.”  Nearly 24 serious skin ailments have been spotted out that happens to be one […]

Leave a Reply

Your email address will not be published. Required fields are marked *

Share via
Facebook
X (Twitter)
LinkedIn
Mix
Email
Print
Copy Link
Copy link
CopyCopied